BioCardia (BCDA) Q4 2022 Earnings Report

388 Followers

BCDA Q4 2022 EPS Results

Actual EPS-$2.55

Consensus EPS-$2.70

Beat/MissBeat by +$0.15

One Year Ago EPS-$3.15

Actual Revenue$106.00K

Expected Revenue$153.00K

Beat/MissMissed by -$47.00K

YoY Revenue Growth+34.18%

QuarterQ4 2022

Date03/29/2023

TimeBefore Open

Conference CallWednesday, March 29, 2023

BCDA Upcoming Earnings

BioCardia's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

BCDA Q4 2022 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.13 / -	-0.24	―
Aug 12, 2026	2026 (Q2)	-0.18 / -0.13	-0.4	67.50% (+0.27)
May 15, 2026	2026 (Q1)	-0.17 / -0.21	-0.59	64.41% (+0.38)
Mar 24, 2026	2025 (Q4)	-0.17 / 0.00	-0.06	―
Nov 12, 2025	2025 (Q3)	-0.23 / -0.24	-0.61	60.66% (+0.37)
Aug 11, 2025	2025 (Q2)	-0.50 / -0.40	-0.88	54.55% (+0.48)
May 14, 2025	2025 (Q1)	- / -0.59	-1.35	56.30% (+0.76)
Mar 26, 2025	2024 (Q4)	-0.63 / -0.06	-1.35	95.56% (+1.29)
Nov 13, 2024	2024 (Q3)	-1.19 / -0.61	-1.8	66.11% (+1.19)
Aug 13, 2024	2024 (Q2)	-0.10 / -0.88	-2.55	65.49% (+1.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed